[an error occurred while processing this directive] | ����Ƥ���Բ�ѧ��־ 2004, 30(3) 164-166 DOI: ISSN: 2096-5540 CN: 32-1880/R | ||||||||||||||||||||||||||||||||||||||||||||
����Ŀ¼ | ����Ŀ¼ | ������� | ������ [��ӡ��ҳ] [�ر�] | |||||||||||||||||||||||||||||||||||||||||||||
���� |
| ||||||||||||||||||||||||||||||||||||||||||||
Ѫ����Ƥ�������Ӽ�����Ƥ�����еı�� | |||||||||||||||||||||||||||||||||||||||||||||
���緼, ���� | |||||||||||||||||||||||||||||||||||||||||||||
����ҽ�ƴ�ѧ�����ڶ�ҽԺƤ���� 116027 | |||||||||||||||||||||||||||||||||||||||||||||
ժҪ��
Ѫ����Ƥ����������һ����Ƥϸ����������˿����ԭ,������Ͳ���״̬�¾��б��ۺϽ������������,�ع���Ѫ����Ƥ�������Ӽ������������ѧ����,��������Ѫ����Ƥ���������ڸ���Ƥ�����еı����ٴ����塣 | |||||||||||||||||||||||||||||||||||||||||||||
�ؼ����� ��Ƥ�������� Ƥ������ | |||||||||||||||||||||||||||||||||||||||||||||
Abstract: | |||||||||||||||||||||||||||||||||||||||||||||
Keywords: | |||||||||||||||||||||||||||||||||||||||||||||
�ո����� 2003-07-01 ������ ����淢������ | |||||||||||||||||||||||||||||||||||||||||||||
DOI: | |||||||||||||||||||||||||||||||||||||||||||||
������Ŀ: | |||||||||||||||||||||||||||||||||||||||||||||
ͨѶ����: | |||||||||||||||||||||||||||||||||||||||||||||
�����: | |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||
�ο����ף� | |||||||||||||||||||||||||||||||||||||||||||||
[1] Risau W. Mechanisms of angiogenesis. Nature, 1997, 386:671-674. [2] Bussolati B, Dunk C, Grohman M, et al. Vascular endothelial growth factor receptor-l modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol, 2001, 759:993. [3] Brown LF, Harrist TJ, Yeo KT, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol, 1995, 104:744-749. [4] Pepper MS, Ferrara N, Orci L, et al. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvaseular endothelial cells. Biochem Biophys Res Commun, 1991, 181:902-906. [5] Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical eytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol, 2002, 20:4368-4380. [6] Gerber HP, Malik AK, Solar GP, et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature, 2002, 417:954-958. [7] Houck KA, Leung DW, Rowland AM, et al. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem, 1992, 267:26031-26037. [8] Detmar M, Brown LF, Claffey KP, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med, 1994, 180:1141-1146. [9] Ling S, Yamasaki K, Shirakata Y, et al. Vascular endothelial growth factor is overexpressed in lichen planus keratinocytes and its expression correlates with increased dermal microvessels in lesional skin. Jpn J Dermatol, 2000, 110:1395-1402. [10] Harada K, Baillie R, Lu S, et al. VEGF expression in skin warts.Relevance to angiogenesis and vasodilation. Arch Dermatol Res,2001, 293:233-238. [11] Viac J, Palacio S, Schmitt D, et al. Expression of vascular endothelial growth factor in uormal epidermis, epithelial tumors and cultured keratinocytes. Arch Dermatol Res, 1997, 289:158-163. [12] Neuchrist C, Quint C, Pammer A, et al. Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study. Acta Otolaryngol,1999, 119:732-738. [13] Weninger W, Uthnan A, Pammer J, et al. Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab Invest, 1996, 75:647-657. [14] Bowden J, Brennan PA, Umar T, et al. Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck. J Cutan Pathol, 2002, 29:585-589. [15] Nakashima T, Hudson JM, Clayman GL. Antisense inhibition of vascular endothelial growth factor in human head and neck squamous cell carcinoma. Head Neck, 2000, 22:483-488. [16] Shemirani B, Crowe DL. Head and neck squamous cell carcinoma lines produce biologically active angiogenic factors. Oral Oncol,2000, 36:61-66. [17] Toth-Jakatics R, Jimi S, Takebayashi S, et al. Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. Hum Pathol, 2000, 31:955-960. [18] Yu JL, Rak JW, Klement G, et al. Vascular endothelial growth factor isoform expression as a determinant of blood vessel patterning in human melanoma xenografts. Cancer Res, 2002, 62:1838-1846. [19] Mackiewicz Z, Sukura A, Povilenaite D, et al. Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin. Clin Exp Rheumatol, 2002,20:641-646. |
|||||||||||||||||||||||||||||||||||||||||||||
������������� | |||||||||||||||||||||||||||||||||||||||||||||
1���Ų�Ƽ,���̸�.��м��Ѫ���쳣�������Ƽ����ƶԲ�[J]. ����Ƥ���Բ�ѧ��־, 2006,32(1): 23- | |||||||||||||||||||||||||||||||||||||||||||||
2�����M, Ϳ��ͥ.Ѫ����Ƥ�������Ӻ�Ƥ������[J]. ����Ƥ���Բ�ѧ��־, 2003,29(2): 97-99 | |||||||||||||||||||||||||||||||||||||||||||||
3�����Ѳ�, ���.����Ѫ�ܻ�����������м��[J]. ����Ƥ���Բ�ѧ��־, 2005,31(2): 99-101 | |||||||||||||||||||||||||||||||||||||||||||||
4���Ų�Ƽ, ���̸�.��м��Ѫ���쳣�������Ƽ����ƶԲ�[J]. ����Ƥ���Բ�ѧ��־, 2006,32(1): 23-25 | |||||||||||||||||||||||||||||||||||||||||||||
5����С�� κ־ƽ ����Ⱥ.ɫ����Ƥ������������м�������е�����[J]. ����Ƥ���Բ�ѧ��־, 2014,40(4): 234-236 | |||||||||||||||||||||||||||||||||||||||||||||
�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���ص�����!�������ݲ�����վ�۵�.) | |||||||||||||||||||||||||||||||||||||||||||||
Copyright 2008 by ����Ƥ���Բ�ѧ��־ |